Differential interactions of muscarinic drugs with binding sites of [ 3 H]pirenzepine and [ 3 H]quinuclidinyl benzilate in rat brain tissue
- 30 April 1987
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 40 (20), 1981-1987
- https://doi.org/10.1016/0024-3205(87)90287-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- In vitro interaction of ACTH with rat brain muscarinic receptorsPeptides, 1986
- Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studiesBrain Research, 1986
- Autoradiographic localization of muscarinic agonist binding sites in the rat central nervous system with (+)-cis-[3H]methyldioxolaneBrain Research, 1985
- Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepineLife Sciences, 1984
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- Muscarinic receptor subclassesTrends in Pharmacological Sciences, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- [3H] pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortexLife Sciences, 1982
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973